Prostate cancer is the second-leading cause of death in American men. However, prostate cancer is curable, thanks to options ...

Only men with prostate tumors of the luminal B subtype benefited from adding apalutamide to salvage radiation in the phase 2 ...

The study found that patients with luminal B subtype prostate cancer benefited from the addition of hormone therapy to ...

RICHMOND, Va. — A groundbreaking treatment for prostate cancer now available in Virginia aims to improve patient outcomes while minimizing side effects associated with traditional surgeries and ...

When a slow-growing prostate cancer showed signs of progressing, Dave Donaldson's enlarged prostate almost got in the way of the most effective treatment. But the team approach to urology at Fox Chase ...

NucleoBio, Corp., a leading biotechnology innovator in precision oncology diagnostics, and PreCheck Health Services, a high-complexity CLIA-certified and CAP-accredited clinical laboratory, today ...

It’s the second most common type of cancer among men and affects 1 in every 8 men in the United States. September is Prostate Cancer Awareness Month, and the American Cancer Society says this type of ...

This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer .

Molecular evolution of HRR gene alterations in metastatic prostate cancer: A ctDNA-based study. This is an ASCO Meeting Abstract from the 2025 ASCO Genitourinary Cancers Symposium. This abstract does ...